T
Timothy M. McCashland
Researcher at University of Nebraska Medical Center
Publications - 92
Citations - 8485
Timothy M. McCashland is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 39, co-authored 91 publications receiving 7765 citations. Previous affiliations of Timothy M. McCashland include University of Nebraska–Lincoln & University of Nebraska Omaha.
Papers
More filters
Journal ArticleDOI
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
George Ostapowicz,Robert J. Fontana,Frank V. Schioødt,Anne M. Larson,Timothy J. Davern,Steven Han,Timothy M. McCashland,A. Obaid Shakil,J. Eileen Hay,Linda S. Hynan,Jeffrey S. Crippin,Andres T. Blei,Grace Samuel,Joan S. Reisch,William M. Lee,Raj Santyanarayana,Cary Caldwell,Lawton Shick,Nathan M. Bass,Smita Rouillard,E Atillasoy,Steven L. Flamm,Kent G. Benner,Hugo R. Rosen,Paul Martin,Rise Stribling,Eugene R. Schiff,Maria Torres,Victor J. Navarro,Brendan M. McGuire,Raymond T. Chung,Diane R. Abraczinskas,Jules L. Dienstag +32 more
TL;DR: The primary aim was to compare presenting clinical features and liver transplantation in patients with acute liver failure related to acetaminophen hepatotoxicity, other drugs, indeterminate factors, and other causes.
Journal ArticleDOI
High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor,Kris V. Kowdley,Velimir A. Luketic,M. Edwyn Harrison,Timothy M. McCashland,Alex S. Befeler,Denise M. Harnois,Roberta A. Jorgensen,Jan Petz,Jill C. Keach,Jody Mooney,Carol Sargeant,Tamara Bernard,Debra King,Ellen Miceli,Jeff Schmoll,Tanya L. Hoskin,Prabin Thapa,Felicity Enders +18 more
TL;DR: Long‐term, high‐dose UDCA therapy is associated with improvement in serum liver tests in PSC but does not improve survival and was associated with higher rates of serious adverse events.
Journal ArticleDOI
Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure
William M. Lee,Linda S. Hynan,Lorenzo Rossaro,Robert J. Fontana,R. Todd Stravitz,Anne M. Larson,Timothy J. Davern,Natalie Murray,Timothy M. McCashland,Joan S. Reisch,Patricia R. Robuck +10 more
TL;DR: Intravenous NAC improves transplant-free survival in patients with early stage non-acetaminophen-related acute liver failure and typically require emergency liver transplantation.
Journal ArticleDOI
The North American Study for the Treatment of Refractory Ascites
Arun J. Sanyal,Chris Genning,K. Rajender Reddy,Florence Wong,Kris V. Kowdley,Kent G. Benner,Timothy M. McCashland +6 more
TL;DR: Although TIPS plus medical therapy is superior to medical therapy alone for the control of ascites, it does not improve survival, affect hospitalization rates, or improve quality of life.
Journal ArticleDOI
Etiology and outcome for 295 patients with acute liver failure in the united states
Frank V. Schiødt,E. Atillasoy,A. O. Shakil,E. R. Schiff,Cary Caldwell,Kris V. Kowdley,Rise Stribling,J. S. Crippin,S. Flamm,K. A. Somberg,H. Rosen,Timothy M. McCashland,J. E. Hay,William M. Lee,H. Bodenheimer,J. Rakela,K. G. Benner,P. Martin,S. H B Han,A. T. Blei,S. D. Lidofsky,S. Rouillard,T. Davern,R. H. Wiesner,M. K. Porayko,M. G. Peters,R. L. Carithers,A. G. Tzakis,M. J. Rodriguez +28 more
TL;DR: Age did not differ between survivors and nonsurvivors, perhaps reflecting a selection bias for patients transferred to liver transplant centers, but showed a trend toward affecting both survival and transplantation rate.